Autopsy report · NCT03104998
Neotililty Trial: Effect of Coenzyme Q10 on Semen Parameters in Men With Idiopathic Infertility
Cause of deathSlow enrollment
“No further patient enrollment”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 4
- Sponsor
- PharmEvo Pvt Ltd
- Sponsor type
- Industry
- Conditions
- Idiopathic Infertility
- Interventions
- Coenzyme Q10
- Participants
- 0
- Sites
- 1
- Countries
- Pakistan
Trials that died the same way
- Betadine Bladder Irrigations vs. Standard of Care Prior to Indwelling Catheter Removal
“Lack of Patient Enrollment” - Human Brain Adaptation to Chronic Pain and Its Effects on Opioid Use
“Insufficient patient enrollment.” - Tacks Versus Glue for Mesh Fixation in Laparoscopic Ventral Hernia Repair Treating Defects Between 2 and 5 cm Width
“Limited patient enrollment” - The Effect of Pain Medication in Children With Acute Abdominal Pain and Its Implication Over the Surgeon's Decision
“Unable to enroll more patients” - Intravitreal Dexamethasone Implant (Ozurdex) Versus Bevacizumab in Patients With Diabetic Macular Edema Undergoing Cataract Surgery
“Inadequate patient enrollment”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.